Home Health Type A haemophilia, the idea that made gene therapy more effective

Type A haemophilia, the idea that made gene therapy more effective

by admin

The principle is the same: to provide what is missing. But the difference is substantial: in one case what is missing comes from the outside, it must always be available and taken on at regular intervals. In the other it is enough – or more cautiously it would be enough – a single administration to ensure a continuous endogenous production, through gene therapy.

Let’s talk about coagulation factor VIII, absent in type A haemophilia: a study, just published in the New England Journal of Medicine, shows that it is possible to ensure its production for more than two years in some haemophilia patients, reducing the risk of bleeding.

.

See also  Salmonella, summer arrives: beware of eggs, chicken and pork
0 comment
0

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy